ArticleOncotarget2017
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.
Maria Kissel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ArticleOncotarget2017
Maria Kissel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.